Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/149576

Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

There is a subtype of breast cancer characterized by the overexpression of the oncogene HER2. Although most patients with this diagnosis benefit from HER2-targeted treatments, some do not respond to these therapies and others develop resistance with time. New tools are therefore warranted for the treatment of this patient population, and for early identification of those individuals at a higher risk of developing innate or acquired resistance to current treatments. Here, we show that HER2 forms heteromer complexes with the cannabinoid receptor CB2R, the expression of these structures correlates with poor patient prognosis, and their disruption promotes antitumor responses. Collectively, our results support HER2-CB2R heteromers as new therapeutic targets and prognostic tools in HER2+ breast cancer

Matèries (anglès)

Citació

Citació

BLASCO-BENITO, Sandra, MORENO GUILLÉN, Estefanía, SEIJO-VILA, Marta, TUNDIDOR, Isabel, ANDRADAS, Clara, CAFFAREL, María m., CARO-VILLALOBOS, Miriam, URIGÜEN, Leyre, DIEZ-ALARCIA, Rebeca, MORENO-BUENO, Gema, HERNÁNDEZ, Lucía, MANSO, Luis, HOMAR RUANO, Patricia c., MCCORMICK, Peter j., BIBIC, Lucka, BERNADÓ MORALES, Cristina, ARRIBAS, Joaquín v. (vicente), CANALS BUJ, Meritxell, CASADÓ, Vicent, CANELA CAMPOS, Enric i. (enric isidre), GUZMÁN, Manuel, PÉREZ-GÓMEZ, Eduardo, SÁNCHEZ MORA, Cristina. Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer. _Proceedings of the National Academy of Sciences of the United States of America - PNAS_. 2019. Vol. 116, núm. 9, pàgs. 3863-3872. [consulta: 27 de gener de 2026]. ISSN: 0027-8424. [Disponible a: https://hdl.handle.net/2445/149576]

Exportar metadades

JSON - METS

Compartir registre